Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central nervous system sarcoidosis.

A Stoudemire, E Linfors, J L Houpt

    General Hospital Psychiatry
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Central nervous system (CNS) sarcoidosis affects about 5% of patients, presenting with neurological and psychiatric symptoms. Diagnosis can be challenging, even with normal cerebrospinal fluid (CSF), and steroids are a primary treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recruitment into psychiatry.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Integrating medical and psychiatric treatment in an inpatient medical setting.

    Psychosomatics·2000
    Same author

    Quo vadis, psychiatry? Problems and potential for the future of medical student education in psychiatry.

    Psychosomatics·2000
    Same author

    Medical assessment of patients presenting with psychiatric symptoms in the emergency setting.

    The Psychiatric clinics of North America·2000
    Same author

    Qualitative outcome assessment of a medical ethics program for clinical clerkships: a pilot study.

    General hospital psychiatry·1999
    Same author

    Neuropsychiatric toxicity associated with cytokine therapies.

    Psychosomatics·1999

    Area of Science:

    • Neurology
    • Neuroimmunology
    • Systemic Inflammatory Diseases

    Background:

    • Sarcoidosis is a multisystem inflammatory disease of unknown etiology.
    • Central nervous system (CNS) involvement occurs in approximately 5% of sarcoidosis cases.
    • Neurological manifestations can range from cranial nerve palsies to parenchymal brain lesions.

    Observation:

    • CNS sarcoidosis presents with diverse neurological and psychiatric symptoms, including delirium and choreoathetosis.
    • Diagnosis relies on a combination of clinical findings, CSF analysis, and evidence of sarcoidosis in other organs.
    • Cerebrospinal fluid (CSF) may be normal in up to 30% of patients, complicating diagnosis.

    Findings:

    • The abstract highlights the diagnostic complexities of CNS sarcoidosis.

    Related Experiment Videos

  • A case presentation illustrates the challenges in diagnosing CNS sarcoidosis presenting with delirium and choreoathetosis.
  • Steroids are identified as the primary therapeutic agent.

    • Implications:

    • Early recognition and diagnosis of CNS sarcoidosis are crucial for effective management.
    • Understanding the varied presentations is key for clinicians managing patients with suspected neurosarcoidosis.
    • Further research may elucidate more sensitive diagnostic markers and treatment strategies for CNS sarcoidosis.